A New Approach to Mental Wellness
EXOMIND® is a non-invasive treatment designed to support patients experiencing sleep disruption, anxiety, brain fog, emotional lability, and other challenges commonly associated with perimenopause and menopause.
Because Hormonal Changes Affect More Than Your Physical Health
Perimenopause and menopause can impact sleep, mood, focus, motivation, and overall quality of life. Dr. Gertenstein offers EXOMIND® as a non-invasive treatment option for women looking for support through these transitions.
A Health Canada Approved Treatment
EXOMIND® is Health Canada approved for the treatment of Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), and Binge Eating Disorder (BED).
EXOMIND® may also support mood, focus, and overall mental wellbeing through its effects on brain health.
What is EXOMIND®?
EXOMIND® uses Transcranial Magnetic Stimulation (TMS) technology, a clinically studied treatment that has been used for over 40 years, to stimulate areas of the brain associated with mood, focus, motivation, emotional regulation, and stress response. The treatment is non-invasive, drug-free, and requires no downtime.
Who May Benefit From EXOMIND®?
-

Emotional Wellbeing
-

Reduced Motivation
-

Anxiety & Depression
-

Poor Sleep
-

Brain Fog
-

Difficulty Focusing
Meet Dr. Gertenstein
Dr. Gertenstein is a Winnipeg-based physician specializing in Obstetrics & Gynecology, dedicated to providing thoughtful, evidence-informed care in a supportive and approachable environment.
She offers EXOMIND® as a non-invasive treatment option to support focus, emotional wellbeing, stress resilience, and overall mental wellness.